R. Matthew Neff, Director at BIOANALYTICAL SYSTEMS INC (BASI), bought 5,000 shares at $1.66 ($8K) on 2018-09-14, disclosed to the SEC on 2018-09-18.
Open-market purchase of $8k BASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 2,500 | $4K | 49.8% |
| 2 | $1.66 | 2,500 | $4K | 50.2% |
| Total | $1.66 avg | 5,000 | $8K | 100% |
| Filing → |
| NOTV | SELL | 2025-10-03 | $3K | — | Filing → |
| NOTV | SELL | 2025-09-04 | $3K | — | Filing → |
| NOTV | SELL | 2025-08-04 | $4K | — | Filing → |